Transplant Donor SiteBone Marrow TransplantationTissue DonorsBone MarrowLiving DonorsBone Marrow CellsKidney TransplantationTransplantation, HomologousGraft vs Host DiseaseBone and BonesWhole-Body IrradiationLeukemiaAnemia, AplasticTransplantation, AutologousCytomegalovirus InfectionsHematopoietic Stem Cell TransplantationHematopoietic Stem CellsGraft SurvivalHistocompatibility TestingTransplantation ConditioningBone RemodelingBone Marrow DiseasesImmunosuppressive AgentsHematologic NeoplasmsBone Marrow ExaminationHistocompatibilityBone Marrow PurgingImmunocompromised HostBone Marrow NeoplasmsOpportunistic InfectionsImmunosuppressionLeukemia, Myeloid, AcuteGraft RejectionTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematopoiesisTransplantation ChimeraMice, Inbred C57BLPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporineBone DensityBlood DonorsTreatment OutcomeMycosesRecurrenceRadiation ChimeraCytomegalovirusRetrospective StudiesBusulfanFatal OutcomeBone ResorptionAcute DiseaseTransplantation, IsogeneicColony-Forming Units AssayHLA AntigensHematologic DiseasesPneumonia, ViralNuclear FamilyLymphocyte DepletionCyclophosphamideSurvival AnalysisGanciclovirGraft vs Host ReactionT-LymphocytesCombined Modality TherapyMyelodysplastic SyndromesAspergillosisCell DifferentiationLeukemia, MyeloidBlood Group IncompatibilityTransplantsBone NeoplasmsHepatic Veno-Occlusive DiseaseCystitisPolymerase Chain ReactionMucormycosisCells, CulturedLymphoma, Non-HodgkinFlow CytometryAntilymphocyte SerumLymphocyte TransfusionChimeraBone DevelopmentLeukocyte CountSpleenRemission InductionBone DiseasesPostoperative ComplicationsAntigens, CD34Survival RateFollow-Up StudiesLeukocyte TransfusionMice, Inbred BALB CHerpesvirus 6, HumanInfectionMultiple MyelomaBK VirusBlood CellsGranulocytesDisease-Free Survival